Indivior PLC (NASDAQ:INDV) Receives Consensus Recommendation of “Buy” from Analysts

Indivior PLC (NASDAQ:INDV) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and two have given a strong buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $32.1667.

A number of research analysts have weighed in on the company. HC Wainwright raised their price objective on Indivior from $28.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, October 30th. Craig Hallum reiterated a “buy” rating and issued a $41.00 price objective on shares of Indivior in a report on Friday, October 31st. Northland Securities set a $40.00 target price on shares of Indivior in a research note on Friday, October 31st. Zacks Research raised Indivior from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 3rd. Finally, Piper Sandler restated an “overweight” rating and issued a $41.00 price target (up previously from $27.00) on shares of Indivior in a research note on Friday, October 31st.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. CWM LLC acquired a new stake in Indivior during the third quarter worth approximately $25,000. Quarry LP purchased a new stake in shares of Indivior in the third quarter valued at about $26,000. Raymond James Financial Inc. acquired a new stake in Indivior during the 2nd quarter worth approximately $26,000. Plato Investment Management Ltd acquired a new stake in shares of Indivior during the third quarter worth $52,000. Finally, Blue Trust Inc. acquired a new stake in shares of Indivior in the 3rd quarter worth $99,000. Hedge funds and other institutional investors own 60.33% of the company’s stock.

Indivior Price Performance

Shares of INDV stock opened at $32.75 on Monday. The company has a market cap of $4.52 billion, a price-to-earnings ratio of 52.82 and a beta of 0.68. Indivior has a 1-year low of $7.62 and a 1-year high of $33.30. The stock has a 50 day simple moving average of $26.37 and a 200-day simple moving average of $20.45.

Indivior (NASDAQ:INDV) last announced its earnings results on Thursday, October 30th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.34. The business had revenue of $314.00 million for the quarter, compared to analyst estimates of $257.66 million. Indivior had a net margin of 6.65% and a negative return on equity of 86.28%. Indivior has set its FY 2025 guidance at EPS. Analysts anticipate that Indivior will post 1.22 earnings per share for the current fiscal year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.